FIELD: medicine.
SUBSTANCE: present invention relates to the treatment of cholestatic itching. A method for the treatment of cholestatic itching related to primary biliary cholangitis includes oral administration of a compound, which is seladelpar or its pharmaceutically acceptable salt.
EFFECT: development of a method for the treatment of cholestatic itching.
6 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF INTRAHEPATIC CHOLESTATIC DISEASES | 2017 |
|
RU2765460C2 |
| METHODS OF USING AGONISTS FXR | 2017 |
|
RU2737324C2 |
| METHODS OF TREATING CHOLESTASIS | 2020 |
|
RU2829466C2 |
| METHODS FOR INCREASING HEIGHT OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE | 2020 |
|
RU2822484C2 |
| USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS | 2014 |
|
RU2666219C2 |
| FXR AGONISTS APPLICATION METHODS | 2017 |
|
RU2743075C2 |
| ANTAGONISTS OF TOL-LIKE RECEPTOR 4 AND USE IN AUTOIMMUNE LIVER DISEASES | 2016 |
|
RU2707560C2 |
| PHARMACEUTICAL COMPOSITIONS SUITABLE FOR DELIVERY TO JOINT AND THEIR USE IN TREATMENT OF JOINT PAIN | 2019 |
|
RU2810788C2 |
| COMPOSITIONS AND METHODS FOR MYELOFIBROSIS TREATMENT | 2011 |
|
RU2616262C2 |
| BENZOTHIADIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838136C1 |
